来源:金融时报、CACLP据悉,全球生命科学巨头赛默飞世尔科技公司正以约40亿美元(约合人民币287.24亿)的价格出售部分诊断业务。该公司近期已通过顾问机构接触多家私募股权公司,试探其对包括微生物检测部门(生产传染病检测设备)在内的诊断业务的收购意向。待售的诊断业务部门年调整后收益约3亿美元,年销售额达14亿美元,约占赛默飞世尔整体专业诊断事业部收入的三分之一。知情人士补充称,公司期望以超40...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.